FEF25-75 Might Be a Predictive Factor for Bronchial Inflammation and Bronchial Hyperreactivity in Adolescents with Allergic Rhinitis

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue , 2011, Pages 17-20

  Ciprandi, Giorgio ^a   Tosca, M A ^b   Castellazzi, A M ^c   Cairello, F ^c   Salpietro, C ^d   Arrigo, T ^d   Del Giudice, Miraglia M ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

adolescents; Allergic rhinitis; asthma; BHR; FEF25 75; FeNO

Indexed keywords

EXHALED NITRIC OXIDE; METHACHOLINE; NITRIC OXIDE; UNCLASSIFIED DRUG; BRONCHOCONSTRICTING AGENT; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CLINICAL EXAMINATION; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SKIN; SPIROMETRY; BREATH ANALYSIS; COHORT ANALYSIS; DOSE RESPONSE; HAY FEVER; METABOLISM; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY; VITAL CAPACITY;

ADOLESCENT; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; BRONCHOCONSTRICTOR AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SPIROMETRY; VITAL CAPACITY;

EID: 84856383996     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320110240S404     Document Type: Article

References (23)

1. Bugiani M, Carosso A, Migliore E, Piccioni P, Corsico A, Olivieri M, et al. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy. 2005; 60: 165-70.
2. Asher I,. ISAAC International Study of Asthma and Allergies in Childhood. Pediatr Pulmonol. 2007; 42: 100.
3. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ,. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000; 161: 2051-7.
4. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Grit Care Med. 2001; 164: 858-65.
5. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care. 2000; 162: 920-4.
6. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26: 948-68.
7. Miller MR, Hankinson J, Brusasco V, Burgos R, Casaburi R, Coates R, et al. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-38.
8. Ferguson AC,. Persisting airway obstruction in asymptomatic children with asthma with normal espiratory flow rates. J Alergy Clin Immunol 1988; 82: 19-22
9. Lipworth BJ, Clark DJ,. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax. 1997; 52: 1016-21.
10. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA, Passalacqua G, Pallestrini E, et al. Seasonal and perennial allergic rhinitis: Is this classification adherent to real life? A population based study. Allergy. 2005; 60: 882-7.
11. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008; 63: S8-160.
12. Wallace DV, Dykewicz MS,. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008; 122: S1-84.
13. Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF, Szefler SJ, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ration in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010; 126: 527-34
14. Katelaris CH, Allergic rhinitis and asthma: Epidemiological evidence for the link. Clin Exp All rev 2003; 3: 5-8
15. Townley RG, Ryo UY, Kolotkin BM, Kang B, Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975; 56: 429-42
16. Braman SS, Barrows AA, DeCotis BA,. Airways hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest 1987; 91. 671-4
17. Verdiani P, Di Carlo S, Baronti A, Different prevalence and degree of nonspecific bronchial hyperreactivity in rhinitis. J Allergy Clin Immunol 1990; 86: 576-82
18. Cirillo I, Klersy C, Vizzaccaro A, Pallestrini E, Tosca M, Ciprandi G,. Role of FEF 25-75 as a predictor of bronchial hyperreactivity in allergic patients. Ann Allergy Asthma Immunol 2006; 96: 692-700
19. 1 values. J Allergy Clin Immunol 2010; 126: 527-34 +.
20. American Thoracic Society, European Respiratory Society, ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide 2005. Am J Respir Crit Care Med 2005; 171: 912-30
21. Dreborg S, (Ed.). EAACI Subcommittee on Skin Tests. Skin tests used in type I allergy testing. Position Paper. Allergy 1989; 44 (Suppl.l0): 22-31
22. American Thoracic Society. Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Resp Crit Care Med. 2000; 161: 309-29.
23. 25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol. 2006; 20: 641-7.